In rat models of diabetes‐induced obesity, the activation of monocytes in the kidneys and heart, along with inflammatory and fibrotic responses, is decreased by β2‐AR agonists, providing defense against complications in the kidneys and heart caused by diabetes [7]. Here, ADRB2 is linked to obesity disorder.